Doing what you’ve always done will get you what you’ve always got, and to reach our aim of 3 in 4 people surviving cancer by 2034, we need to think differently.
One of the world’s leading experts in childhood brain tumours, Richard has led international efforts that have dramatically advanced knowledge of their biology.
We look at how Tomas Lindahl’s discoveries have profoundly changed our understanding of cell response to cytotoxic therapies and the implications of this.
Developing partnerships and working collaboratively are underlying principles of our Research Strategy and is necessary in the global fight against cancer.
Our commercialisation arm, Cancer Research Technology, gets innovative new treatments and tests to patients as quickly as possible.